Page last updated: 2024-08-17
carbostyril and Dysplastic Nevus Syndrome, Hereditary
carbostyril has been researched along with Dysplastic Nevus Syndrome, Hereditary in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bosenberg, MW; Held, MA; Iyidogan, P; Klein, M; Koo, AB; Langdon, CG; Liu, Z; Mamillapalli, R; Meeth, K; Platt, JT; Stern, DF | 1 |
Other Studies
1 other study(ies) available for carbostyril and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors.
Topics: Animals; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Indoles; Male; Melanoma; Melanoma, Cutaneous Malignant; Mice, Nude; Mutation; Neoplasm Proteins; Protein Kinase Inhibitors; Quinolones; Signal Transduction; Skin Neoplasms; Small Molecule Libraries; Sulfonamides; Vemurafenib | 2015 |